Clinical Trial Explores Azithromycin, Hydroxychloroquine Combo as COVID-19 Treatment

Clinical Trial Explores Azithromycin, Hydroxychloroquine Combo as COVID-19 Treatment: Rutgers Cancer Institute of New Jersey will be conducting a clinical trial assessing whether azithromycin combined with hydroxychloroquine is better than hydroxychloroquine alone as a potential treatment for patients diagnosed with COVID-19. (Source: CancerNetwork)